Recently I did a project that served as a retrospective analysis of the asset swap between Boehringer Ingelheim and Sanofi.

I have been a big fan of Johnson & Johnson (J&J, or on the stock ticker, JNJ) for many years.

This blog post is going to be a bit of a different beast. I will be talking about changes in the specialty chemicals distribution market,...

An Initial Public Offering (IPO) is an exciting time when a privately-held company makes its shares publicly available for the first...